Venera Kuci Emruli (Former)
1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
(
- Contribution to journal › Article
- 2021
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
(
- Contribution to journal › Article
- 2019
-
Mark
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2018
-
Mark
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity
(
- Contribution to journal › Article
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors
(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
2016) In Leukemia & Lymphoma(
- Contribution to journal › Article
-
Mark
Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
A Molecular Dissection of Mantle Cell Lymphoma - From gene expression analysis to functional evaluation of selected targets
2016)(
- Thesis › Doctoral thesis (compilation)